Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new study-record version dated 2026-11-09 was added, noting changes to study status and contacts/locations. The 2026-11-02 date no longer appears in the displayed history.SummaryDifference0.2%

- Check20 days agoChange DetectedA new study-record version dated November 2, 2026, was added, covering study status and contacts/locations. The version history now also includes the October 28 and October 30 entries.SummaryDifference0.2%

- Check27 days agoChange DetectedA new study-record revision dated October 26, 2026, updates the study status and contacts/locations. The history also shows the October 23 and October 20 revisions.SummaryDifference0.3%

- Check34 days agoChange DetectedA new study-record version dated 2026-10-14 was added, indicating updates to the trial’s status and contacts/locations.SummaryDifference0.1%

- Check41 days agoChange DetectedA new study-record version dated 2026-10-07 was added, documenting updates to the study status and contacts/locations. The history also reflects the preceding versions dated 2026-10-03 and 2026-10-06.SummaryDifference0.2%

- Check55 days agoChange DetectedA new version 262 dated 2026-09-22 adds the Contacts/Locations and Study Status sections to the study record history; the version dated 2026-09-18 was removed.SummaryDifference0.1%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.